Bio4Dreams
Also known as Bio4Dreams S.p.A.
Milan-based certified life-science incubator (S.p.A., est. 2017) that takes equity stakes in the very-early-stage startups it incubates; holdings in 19–21 companies.
- HEADQUARTERS
- Milan, Italy
- FOUNDED
- 2017
- AUM
- —
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 5 people
FOCUS
- STAGES
- Pre-SeedSeed
- GEOGRAPHY
- Italy
WHAT IT IS
Accelerator / Studio. Accelerators and venture studios that invest their own or programme capital in very early companies, for equity.
ABOUT
Bio4Dreams S.p.A. is a certified incubator (since 2019), accelerator and company builder in the life sciences, headquartered at MIND in Milan with a dozen Italian sites. It was incorporated on 21 September 2017 by partial demerger of Sanipedia s.r.l., taking over Sanipedia’s startup stakes and business nursery. Its incubation paths can include direct investment for shares; per its 2026 release it has evaluated over 2,600 projects, incubated 59 startups and acquired stakes in 21 of them. Its own shareholders include regional finance company Finaosta (€1M capital increase, October 2025) and the PNRR-funded National Biodiversity Future Center (2026).
INVESTMENT THESIS
Very-early-stage life-science ventures from academic research: scouting, company formation, pre-seed and seed investment, incubation and acceleration, fundraising and market access.
PORTFOLIO (15)
- BrainDTechBiotech & Life Sciences
- ChemiCareBiotech & Life Sciences
- Evotion
- ClhepBiotech & Life Sciences
- CP2 BiotechBiotech & Life Sciences
- AvanchairHealthTech
- OaCPBiotech & Life Sciences · since 2026
- StealthMode Financesince 2025
- NanoPhoenix
- BIP
- HiWeiss
- WonderGene
- Labs2Life
- 4F BiotechBiotech & Life Sciences
- Euleria HealthHealthTech · Exited
TEAM
LINKS
FAQ
Bio4Dreams is a accelerator based in Milan, Italy, founded in 2017.
Yes. Bio4Dreams invests directly in private companies.
Bio4Dreams invests at Pre-Seed and Seed stages in Biotech & Life Sciences, HealthTech and Food & Agriculture.
Key people at Bio4Dreams include Laura Iris Ferro (President), Pietro Conti (CEO & Co-Founder), Elisabetta Borello (Co-Founder, VP Strategy & External Relations) and Fabio Bianco (VP Scientific & Corporate Development).
Bio4Dreams's investments include BrainDTech, ChemiCare, Evotion, Clhep, CP2 Biotech, Avanchair, OaCP and StealthMode Finance, among others.
The most recent publicly reported investment by Bio4Dreams is OaCP (Co-investment via SAFE; Bio4Dreams became a shareholder), announced in Jan 2026.
Yes. Bio4Dreams manages capital from outside investors.